Global Clinical Trial Kits Market by Phase (Phase III, Phase I, Phase IV, Phase II), by Service (Logistics, Kitting Solutions) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global clinical trial kits market was valued at USD1.3 billion in 2020. It is expected to grow at an 8.5% compound annual growth rate (CAGR), between 2021 and 2028. The rapid technological advancement, increased R&D investment and a growing number of clinical trial will all contribute to the market's rapid growth. The field of home diagnostics has seen tremendous innovation and progress in the past few years, especially since the COVID-19 epidemic. Home testing is now a common method of conducting clinical research remotely. Remote observation and testing can be more cost-effective and accurate, which will help reduce pressure on healthcare professionals who already have a lot of work, particularly when it comes regular monitoring and testing. To enhance clinical research, professionals are using remote testing and virtual technology more frequently.

Covid-19 also led to increased use of sample collection kit due to the increased focus on patient safety, continuity, and quality of clinical trials. Although the coronavirus pandemic delayed clinical trial development and reduced quality, the introduction decentralized clinical trials has allowed for continued clinical research. COVID-19 has demonstrated that patient-centric sampling can quickly be adopted and provided greater safety for patients and healthcare workers. It also allows large-scale data collection, both diagnostic and public-health. This knowledge can be used to accelerate the implementation patient-centric sampling strategies for clinical trials. Patients can also use highly customized kits to collect their biological samples and send them directly to labs for testing. This eliminates the need to have doctors oversee sample preparation, packing, shipping, and handling.

The clinical trial kit is an essential component in ensuring that clinical trials are conducted in an efficient, consistent, and compliant manner. It is crucial to design the kit in a way that makes it easy for investigators to use and ensures compliance with clinical trial protocols. The kit contains everything you need to ensure that your samples are collected accurately, transported safely, efficiently, and with all the paperwork required.

Clinical trial sponsors have sought an all-in one solution for lab kits over the past 10-15 years. However, this universal approach has its limitations, especially due to temperature restrictions for pharmaceutical items. Many components are needed, including different needle sizes, for the medication, especially biologics. While the experimental drug may need temperature-controlled shipping and storage, ancillary supplies do not need them. Hence, including drug products and ancillary supplies in a single kit may significantly and unnecessarily drive up the costs of temperature-controlled shipping and storage.

Service Insights

In 2020, 54.9% of the market share for clinical trial kits was held by the logistics segment. The clinical trial size is increasing, which has a ripple effect on pharmaceutical packaging. In order to minimize product activation or damage during transport, secondary packaging design is increasingly important. Studies are expanding as authorities push the pharmaceutical industry to study a greater number of patients.

The primary objective of the logistic team is to get samples to the lab as quickly and efficiently as possible. They also offer primary and secondary packaging services for various container types. They can also design patient kits, label them and print them. The clinical trial logistics team handles trial supply randomization, blinding/unblinding, rescue medicine packaging and labeling. They offer a complete comparator-sourcing service as well as release testing and re-packaging as well as labeling for clinical trials.

Phase Insights

Phase III dominated the market in clinical trial kits in 2020, accounting for 53.3% of the total revenue. It is expected to continue its dominance in the future. The market for phase III is influenced by the purpose of testing pharmaceutical drugs in humans to validate the therapeutic efficacy of Phase II on large numbers of patients suffering from a particular disease. This is the transition from drug state to chemical. Many clinical trials that ended in phase II with positive outcomes do not continue to phase III. This is often due to side effects. It is therefore important to conduct more studies.

Phase III is designed to prove the safety and effectiveness of the new medicine or vaccine in the average patient who will be using it. It also confirms the effective dosage levels and uncover adverse effects. Due to the large sample size and complexity of research, this phase has the highest failure rate. Failure can cause financial and human damage. The majority of failures are due to non-compliance in safety and effectiveness.

Regional Insights

North America was the dominant market for clinical trial kits in 2020, accounting for 41.1% of the total revenue. The majority of U.S.-based pharmaceutical companies do their majority of business in this area. Market expansion is being driven by favorable government policies and the presence of many companies that offer technologically advanced services like at-home clinical trials services in the U.S.

The market for clinical trial kit sales in Asia Pacific is expected to grow at 9.9% annually over the forecast period. Asia Pacific is a rapidly-growing market for pharmaceuticals. Asia Pacific is home to more than 60% of the world's population. However, the vast majority of patients are still untreated due to limited access to affordable medical options. This will likely lead to more demand for similar products and services within the region.

Market Share Insights and Key Companies

To expand their market reach and grab a large market share, key market players are pursuing various business strategies. Q2 Solutions is able to assist COVID-19 clinical trial with high-quality infrastructure and global capacity. Q2 Solutions provides cutting-edge technology, such as SARS/CoV-2 virus detection and antibody detection, vaccine neutralization tests, immunologic profiling for humans and SARS/CoV-2 viral genome analyses. The market leader in clinical trial kits is:

• Brooks life science

• Q2 solutions

• Patheon (Thermo-fisher scientific)

• LabCorp drug development

• Charles river laboratories

• LabConnect

• Almac group

• Precision medicine group

• Cerba research

• Alpha laboratories

• Marken

• Clinigen

Up Market Research published a new report titled “Clinical Trial Kits Market research report which is segmented by Phase (Phase III, Phase I, Phase IV, Phase II), by Service (Logistics, Kitting Solutions), By Players/Companies Q2 solutions, Marken, Alpha laboratories, Cerba research, Almac group, Charles river laboratories, LabConnect, Precision medicine group, Clinigen, Brooks life science, Patheon (Thermo fisher scientific), LabCorp drug development”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Clinical Trial Kits Market Report Segments:

The market is segmented by Phase (Phase III, Phase I, Phase IV, Phase II), by Service (Logistics, Kitting Solutions).

Clinical Trial Kits Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Clinical Trial Kits Market

Overview of the regional outlook of the Clinical Trial Kits Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Clinical Trial Kits Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Clinical Trial Kits Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Phase III

                2. Phase I

                3. Phase IV

                4. Phase II

                1. Logistics

                2. Kitting Solutions

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Clinical Trial Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Clinical Trial Kits Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.